Phosphatidylinositol-3-Kinase (PI3K) and Histone Deacetylase (HDAC) Multitarget Inhibitors: An Update on Clinical and Preclinical Candidates.

These limitations have driven a clear trend toward the exploration of alternative scaffolds capable of providing more selective, stable, and safer interactions with the HDAC catalytic zinc ion.

also in 19,460 other papers